TACIANA FURTADO DE MENDONCA BELMONT

Dr. TACIANA FURTADO DE MENDONCA BELMONT

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
ÓPÓ. Do Kleyton Palmeira
Ó. Do Kleyton Palmeira
AFAna Karla da Silva Freire
Ana Karla da Silva Freire
DNDébora Nascimento de Nóbrega
Débora Nascimento de Nóbrega
RSRoberta dos Santos Souza
Roberta dos Santos Souza
IFIsabela Cristina Cordeiro Farias
Isabela Cristina Cordeiro Farias
LVLuydson Vasconcelos
Luydson Vasconcelos

16 September 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MSMaria Mariana Barros Melo Silveira
Maria Mariana Barros Melo Silveira
João Victor Batista CabralJoão Victor Batista Cabral
João Victor Batista Cabral
AXAmanda Tavares Xavier
Amanda Tavares Xavier
KÓKleyton Palmeira Do Ó
Kleyton Palmeira Do Ó
JJJulio Francisco de Moura Junior
Julio Francisco de Moura Junior
DODinaldo Cavalcanti de Oliveira
Dinaldo Cavalcanti de Oliveira

26 February 2023 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
DNDébora Nascimento da Nóbrega
Débora Nascimento da Nóbrega
TCTatiana Lins Carvalho
Tatiana Lins Carvalho
KÓKleyton Palmeira Do Ó
Kleyton Palmeira Do Ó
RLRaul Emídio de Lima
Raul Emídio de Lima
IFIsabela Cristina Cordeiro Farias
Isabela Cristina Cordeiro Farias
LVLuydson Vasconcelos
Luydson Vasconcelos
MicroRNAs are involved in gene regulation in several common liver diseases and may play an essential role in activating hepatic stellate cells. The role of these post-transcriptional regulators in ...

23 April 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
IFIsabela Cristina Cordeiro Farias
Isabela Cristina Cordeiro Farias
TBTACIANA FURTADO DE MENDONCA BELMONT
TACIANA FURTADO DE MENDONCA BELMONT
Patricia MouraPatricia Moura
Patricia Moura
IDIgor Farias Domingos
Igor Farias Domingos
DFDIEGO ARRUDA FALCAO
DIEGO ARRUDA FALCAO
MBMarcos André Cavalcanti Bezerra
Marcos André Cavalcanti Bezerra
Objective: This study has as objective to verify whether MBL2 gene polymorphisms are related to the occurrence of cerebrovascular disease (CD) in sickle cell anemia (SCA) patients. Methods: Overall, 259 unrelated SCA patients were enrolled. The patients were divided into three groups: control group, stroke group ad range of risk group. Peripheral blood samples were collected and DNA extraction was performed. All patients were genotyped for exon 1, promoter region -221 and promoter region -550 of MBL2 gene, along with β-globin gene haplotypes. Results: Concerning the genotyping of the MBL2, there was no difference in the frequency of allelic and genotypic variants of the exon 1 and the promoter regions -221 and -550 of the MBL2 gene among the studied groups. Conclusion: Despite the small number of patients, and the lack of association between MBL2 polymorphisms and CD, our study represents an effort to understand the impact of MBL2 polymorphisms in the clinical outcome of patients with SCA.

22 March 2020 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
AFAna Karla da Silva Freire
Ana Karla da Silva Freire
TBTACIANA FURTADO DE MENDONCA BELMONT
TACIANA FURTADO DE MENDONCA BELMONT
KÓKleyton Palmeira Do Ó
Kleyton Palmeira Do Ó
ASAndreia Soares da Silva
Andreia Soares da Silva
IFIsabela Cristina Cordeiro Farias
Isabela Cristina Cordeiro Farias
MCMaria Do Socorro de Mendonça Cavalcanti
Maria Do Socorro de Mendonça Cavalcanti
Objetivo: analisar as estratégias de cuidado de Enfermagem empregadas no manejo da dor em crianças com anemia falciforme. Método: revisão integrativa da literatura sobre o tema nas bases virtuais de dados Scielo, Lilacs, PubMed, MEDLINE e BDENF nos meses de janeiro e fevereiro de 2020. Resultados: foram selecionados 17 artigos e identificadas duas categorias analíticas: conhecimento dos profissionais e educação das crianças e familiares sobre o processo patológico da dor e tratamento farmacológico e não farmacológico para o manejo da dor. Conclusão: como estratégias no enfrentamento da dor em crianças há o tratamento farmacológico e não farmacológico adequado, além do conhecimento da Enfermagem que previne complicações, bem como a educação das crianças e familiares sobre a doença, que favorece a melhora e adaptação aos sintomas.

29 April 2021 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
ASAndreia Soares da Silva
Andreia Soares da Silva
MCMaria Do Socorro de Mendonça Cavalcanti
Maria Do Socorro de Mendonça Cavalcanti
TBTACIANA FURTADO DE MENDONCA BELMONT
TACIANA FURTADO DE MENDONCA BELMONT
RXRicardo Ximenes
Ricardo Ximenes
ASAline Vieira da Silva
Aline Vieira da Silva
DMDemócrito Miranda-Filho
Demócrito Miranda-Filho
In HIV-infected patients, antiretroviral therapy (ART) is associated to adipose tissue redistribution known as lipodystrophy (LD). This study aimed at verifying the association between the polymorphism of the MMP1 gene (rs1799750) (1G/2G) and the serum levels of matrix metalloproteinase 1 (MMP-1) with LD and its subtypes in people living with HIV on ART. This is a cross-secional study. LD was self-reported. The determination of the MMP1 rs1799750 gene polymorphism was performed by real-time PCR, and the serum concentrations of MMP-1 were quantified by the enzyme-linked immunosorbent assay (ELISA) method. Of 404 participants, 204 (51%) were diagnosed with LD, of whom 89 (43%) had mixed lipodystrophy (ML), 72 (35%) had lipohypertrophy (LH), and 43 (22%) had lipoatrophy (LA). There was an association between the genotypes 1G/1G+1G/2G and higher serum levels of MMP-1 ( p = .025). There was no association of MMP1 (1G/2G) with LD. Other factors associated with LD were current CD4 ≤ 350 [odds ratio (OR) = 4.85, confidence interval (CI) = 1.78–47.99, p = .0033] and serum MMP-1 levels >6.81 (OR = 2.67, CI = 1.21–6.08, p = .0165). Factors associated with ML: current CD4 ≤ 350 (OR = 5.59, CI = 1.69–20.39, p = .006); with LH: number of antiretroviral regimens used: 2 (OR = 2.06, CI = 1.01–4.20, p = .0460) and 3+ (OR = 2.09, CI = 1.00–4.35, p = .0477), and current CD4 ≤ 350 (OR = 2.08, CI = 1.00–4.24, p = .0461); and with LA: current viral load >40 (OR = 2.52, CI = 1.03–5.91, p = .0372) and current use of zidovudine (OR = 2.97, CI = 1.32–6.54, p = .0074). Higher levels of MMP-1 were associated with genotypes 1G/2G+1G/1G and with LD. Other individual risk factors were independently associated with LD, and its subtypes, suggesting that the pathogenesis itself is differently manifested for each type of LD.